Atrial sensing performance of a single-lead VDD pacing system during physical activities.
This study was undertaken to evaluate the atrial sensing performance of a single-lead atrial synchronous-ventricular pacing system during various physical activities on late follow-up. Fourteen patients (mean age 55 +/- 17 years) with a third-degree or high-degree atrioventricular block and normal sinus node function were treated with the single-lead Thera VDD (Medtronic, Inc, Minneapolis, MN) pacemaker system. Mean P-wave amplitude at implantation was 3.2 +/- 1.3 mV. To assess the VDD system performance, P-wave amplitudes during various physical maneuvers (supine, sitting, deep breathing, standing, and exercise; respectively) were measured and atrial sensing was evaluated at a mean follow-up of 11 +/- 4 months. During deep breathing, minimum and maximum P-wave amplitudes (0.8 +/- 0.7, 1.2 +/- 1.0 mV, respectively) were found to be significantly lower than the standing position (minimum, 1.1 +/- 0.9, maximum, 1.4 +/- 1.1 mV P = .02 in both). No significant difference was found during other physical maneuvers. During the testing maneuvers, atrial undersensing was observed in 8 patients (57%) at the nominal atrial sensitivity of 0.5 mV. After increasing the atrial sensitivity (0.25 mV), no sensing failure was observed in these patients. It has been concluded that Medtronic Thera VDD system is a safe and reliable device with an easy implantation technique providing effective atrioventricular synchronization. The sensing problems, which may occur on late follow-up, can be corrected successfully by reprogramming. To achieve an optimal atrial sensing function in patients with a single-lead VDD pacing, we recommend that the atrial sensing capability should be examined in various physical maneuvers.